In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Product Development, heads of regulatory affairs, and commercial directors from OEMs, casting material suppliers, and orthopedic splint manufacturers were examples of supply-side sources. Board-certified orthopedic surgeons, trauma specialists, emergency medicine doctors, cast technicians, procurement leads from hospitals, orthopedic clinics, ambulatory surgical centers, and rehabilitation facilities were among the demand-side sources. Primary research obtained information on clinical adoption trends, pricing tactics, and reimbursement dynamics in addition to validating market segmentation and product pipeline deadlines.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)
By Region: North America (32%), Europe (30%), Asia-Pacific (33%), Rest of World (5%)
Global market valuation was derived through revenue mapping and procedure volume analysis. The methodology included:
Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America
Product mapping across fiberglass splints, plaster splints, thermoplastic splints, 3D-printed custom splints, splinting tools & accessories, and other product categories
Analysis of reported and modeled annual revenues specific to orthopedic splint portfolios
Coverage of manufacturers representing 72-78% of global market share in 2024
Extrapolation using bottom-up (procedure volume × ASP by country/region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations across upper extremity, lower extremity, and spinal applications